- Investing Ideas
- /
- U.S. Undervalued Stocks Based On Cash Flows
U.S. Undervalued Stocks Based On Cash Flows
Results
189
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
189 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
FLNC | US$21.11 | 14.0% | -16.2% | US$3.4b | US$27.37 | PS1.3x | E53.3% | n/a | Capital Goods | ||
EQT | US$32.88 | 0.7% | -23.4% | US$19.1b | US$42.19 | PE28.1x | E40.7% | 1.9% | Energy | ||
DOX | US$85.05 | -2.3% | -2.7% | US$9.8b | US$98.98 | PE19.1x | E24.1% | 2.3% | Software | ||
OC | US$159.90 | -0.05% | 16.9% | US$13.7b | US$186.68 | PE13.2x | E16.7% | 1.5% | Capital Goods | ||
PFIS | US$44.28 | -1.3% | 1.3% | US$449.8m | US$49.00 | PB1.3x | E103.3% | 5.6% | Banks | ||
CADE | US$30.22 | -4.2% | 40.5% | US$5.5b | US$35.58 | PB1.1x | E73.5% | 3.3% | Banks | ||
ALNY | US$261.91 | 3.5% | 23.7% | US$32.9b | US$283.17 | PS14.3x | E65.2% | n/a | Pharmaceuticals & Biotech | ||
FSLR | US$239.84 | 11.3% | 40.7% | US$22.3b | US$284.47 | PE21.3x | E27.0% | n/a | Semiconductors | ||
VSTA | US$2.52 | 6.3% | -39.3% | US$200.2m | US$3.51 | PB0.3x | E86.3% | n/a | Consumer Services | ||
VBTX | US$24.05 | -2.4% | 34.2% | US$1.3b | US$27.20 | PB0.8x | E22.6% | 3.3% | Banks | ||
CTKB | US$5.49 | 5.0% | -24.4% | US$735.1m | US$8.70 | PS3.7x | E111.9% | n/a | Pharmaceuticals & Biotech | ||
WEX | US$192.00 | 2.0% | -4.1% | US$7.9b | US$225.08 | PE32.1x | E31.3% | n/a | Diversified Financials | ||
SE | US$77.95 | -0.3% | 99.7% | US$44.5b | US$85.84 | PS3.1x | E49.4% | n/a | Media | ||
PNFP | US$90.57 | -7.2% | 34.3% | US$7.0b | US$102.92 | PB1.2x | E28.1% | 1.0% | Banks | ||
AVBH | US$19.65 | 0.0005% | -9.2% | US$154.9m | US$23.50 | PB0.9x | E22.3% | n/a | Banks | ||
ZG | US$54.17 | 4.0% | 11.3% | US$12.9b | US$56.36 | PS6.1x | E67.4% | n/a | Real Estate Management and Development | ||
LYV | US$97.33 | 2.2% | 18.0% | US$22.1b | US$118.62 | PE87.7x | E29.3% | n/a | Media | ||
TENB | US$39.00 | -2.2% | -15.9% | US$4.6b | US$51.20 | PS5.5x | E62.2% | n/a | Software | ||
ENV | US$62.65 | -0.3% | 23.9% | US$3.5b | US$64.25 | PS2.6x | E72.8% | n/a | Software | ||
GABC | US$38.08 | -3.4% | 33.3% | US$1.1b | US$42.80 | PB1.6x | E15.1% | 2.8% | Banks | ||
CXT | US$56.09 | -0.7% | -1.8% | US$3.2b | US$80.80 | PE17.7x | E21.9% | 1.1% | Tech | ||
PSTG | US$47.71 | 0.7% | 27.9% | US$15.2b | US$65.06 | PE113.7x | E38.0% | n/a | Tech | ||
VERX | US$35.66 | -2.8% | 66.0% | US$5.6b | US$41.00 | PE280.3x | E38.9% | n/a | Software | ||
SSB | US$91.95 | -3.8% | 32.6% | US$7.1b | US$106.53 | PB1.2x | E28.1% | 2.3% | Banks |